PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 107 filers reported holding PROGENICS PHARMACEUTICALS IN in Q2 2016. The put-call ratio across all filers is 20.80 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $646,000 | +103.1% | 80,388 | +88.5% | 0.03% | +100.0% |
| Q1 2018 | $318,000 | +116.3% | 42,638 | +173.3% | 0.01% | +85.7% |
| Q1 2017 | $147,000 | -34.7% | 15,600 | -56.3% | 0.01% | -90.4% |
| Q3 2016 | $225,000 | -83.2% | 35,700 | -88.4% | 0.07% | +21.7% |
| Q1 2016 | $1,340,000 | +143.2% | 307,523 | +241.6% | 0.06% | +130.8% |
| Q4 2015 | $551,000 | +462.2% | 90,023 | +582.6% | 0.03% | +766.7% |
| Q2 2015 | $98,000 | – | 13,188 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|